Total returns will also consist of earnings growth and dividends. Given the company’s competitive advantages and recent business performance, we feel that a 6% average annual EPS growth rate is achievable over the next five years. Finally, Johnson & Johnson stock has a current dividend yield of...
Dividends Analysis Dividend Ideas Healthcare Johnson & Johnson: Dividend Increase Coming - Here's What To Expect Apr. 05, 2016 6:02 PM ETJohnson & Johnson (JNJ) Stock31 Comments Bob Ciura 2.96KFollowers Summary J&J is a Dividend Aristocrat, with 53 years of consecutive dividend increases un...
Find the latest comments on Johnson & Johnson (JNJ) stock analysis, from Seeking Alpha's very active community.
Withits stock down 6.2% over the past three months, it is easy to disregard Johnson & Johnson (NYSE:JNJ). However, the company's fundamentals look pretty decent, and long-term financials are usuall
Stay up-to-date on Johnson & Johnson Common Stock (JNJ) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.
TheMotley Fool Stock Advisoranalyst team just identified what they believe are the10 best stocksfor investors to buy now... and Johnson & Johnson wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. ...
Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses ...
Johnson & Johnson expects to fund the transaction through a combination of cash on hand and short-term financing. Johnson & Johnson expects to maintain a strong balance sheet and to continue to support its stated capital allocation priorities of R&D investment, competitive dividends, value-creating ...
Johnson & Johnson company earnings calendar and analyst expectations - Upcoming and past events | Nyse: JNJ | Nyse
New Consumer Health Company would be a Global Leader with Iconic Brands and Products that Touch Over One Billion Lives Every Day Johnson & Johnson would Remain a Global Leader in Healthcare, Focused on Major Unmet Medical Needs and Materially ...